El VePesid Genérico se utiliza para tratar a pacientes con cáncer de pulmón y tumores testiculares recurrentes. Se utiliza en combinación con otros medicamentos para el cáncer. El VePesid es un antineoplásico. Funciona al impedir que las células tumorales se dividan (mitosis), lo que previene que ciertos tipos de cáncer se extiendan. Más informaión »
Recibí mi encargo la semana pasada. Muchas gracias. ¡Voy a realizar pronto otro pedido! ¡! Mi mujer estuvo todavía más sorprendida que yo... Volví a ser un joven nuevamente. Gracias:)
- David
Nuestra página de facturación está certificada por:
Diffuse Large B-Cell Lymphoma: Current Treatment Approaches - Cancer Network
Diffuse Large B-Cell Lymphoma: Current Treatment ApproachesCancer Network[32] Patients with an unfavorable interim PET/CT after two cycles of R-CHOP received R-DICEP (rituximab, dose-intensive cyclophosphamide, etoposide, cisplatin) followed by R-BEAM (rituximab, carmustine [BCNU], etoposide, Ara-C [cytarabine], .
Brave boy, 2, successfully battles brain tumour - and doctors hope pioneering ... - Daily Mail
Mitotane plus Chemo Combo May Benefit Adrenocortical Cancer - MD News (press release)
Mitotane plus Chemo Combo May Benefit Adrenocortical CancerMD News (press release)For patients with advanced adrenocortical cancer, mitotane plus a combination of etoposide, doxorubicin, and cisplatin is superior to streptozocin-mitotane for rates of response and progression-free survival, but does not improve overall survival.
Large-scale study finds treatment standard for rare cancer - HealthCanal.com
Large-scale study finds treatment standard for rare cancerHealthCanal.
The Challenge of Answering Multiple Questions in a Single Oncology Trial - Clinical Oncology News
Clinical Oncology NewsThe Challenge of Answering Multiple Questions in a Single Oncology TrialClinical Oncology NewsFortunately, subsequent research revealed that including etoposide, rather than doubling the cisplatin concentration, was the cause of the superior clinical outcomes with this primary chemotherapy program.